|
EIF4G1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.353470E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.444300E-02 |
| Normal-vs-Stage2 |
3.877000E-01 |
| Normal-vs-Stage3 |
1.023620E-03 |
| Normal-vs-Stage4 |
3.204200E-01 |
| Stage1-vs-Stage2 |
9.407600E-01 |
| Stage1-vs-Stage3 |
1.140190E-02 |
| Stage1-vs-Stage4 |
6.294200E-01 |
| Stage2-vs-Stage3 |
5.440400E-02 |
| Stage2-vs-Stage4 |
6.114200E-01 |
| Stage3-vs-Stage4 |
3.419800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.624300E-04 |
| Normal-vs-AfricanAmerican |
1.157680E-02 |
| Normal-vs-Asian |
9.577600E-01 |
| Caucasian-vs-AfricanAmerican |
9.755800E-01 |
| Caucasian-vs-Asian |
3.459200E-01 |
| AfricanAmerican-vs-Asian |
3.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.238570E-03 |
| Normal-vs-Female |
1.042420E-04 |
| Male-vs-Female |
8.228100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.324400E-02 |
| Normal-vs-Extreme_Weight |
2.531600E-02 |
| Normal-vs-Obese |
1.622350E-03 |
| Normal-vs-Extreme_Obese |
2.135600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.768400E-01 |
| Normal_Weight-vs-Obese |
4.585600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.267400E-01 |
| Extreme_Weight-vs-Obese |
3.793600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.034800E-01 |
| Obese-vs-Extreme_Obese |
9.611000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.342900E-03 |
| Normal-vs-Age(41-60Yrs) |
7.353000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.176000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.433600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.052000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.055400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.778200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.856800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.136600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.729000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.179800E-04 |
| Normal-VS-Type2 PRCC |
8.503900E-02 |
| Normal-VS-KIRP CIMP |
9.637400E-03 |
| Normal-VS-Unclassified PRCC |
8.342400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.199000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.322000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.282800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.440020E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.127000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.059210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.291600E-01 |
| Normal-vs-N1 |
1.200730E-03 |
| Normal-vs-N2 |
2.218600E-01 |
| N0-vs-N1 |
5.021300E-03 |
| N0-vs-N2 |
2.584600E-01 |
| N1-vs-N2 |
6.128800E-01 |
|
|
